Target intelligence / Profile preview

Sorbin and SH3 domain-containing protein 3 (SORBS3)

Target
SORBS3
Molecular classification
Other (Cytoskeletal adaptor protein), Enzyme (based on some sources)
01

Overview

Sorbin and SH3 domain-containing protein 3 (commonly known as Vinexin and abbreviated as SORBS3) is a cytoskeletal adaptor protein composed of multiple isoforms, including vinexin-alpha and vinexin-beta, which contain characteristic SH3 (Src homology 3) domains critical for protein–protein interactions[1][2]. It plays a key role in mechanotransduction by regulating the composition and dynamics of focal adhesions and actin cytoskeleton, notably through direct or indirect interactions with proteins such as vinculin and paxillin at sites of cell–extracellular matrix contacts[2][4]. SORBS3 modulates cell spreading, migration, and cellular responses to extracellular matrix stiffness, and it has been shown to negatively regulate autophagy in neurons, with expression levels rising during brain aging[3]. Knockout mouse models for SORBS3 reveal roles in cutaneous wound healing and sensitivity to cardiac hypertrophy, highlighting its functional importance in tissue repair and cardiovascular biology[2][3]. SORBS3 is not generally considered a therapeutic target for drug intervention at this time and no direct pharmacological modulators are documented in current literature.

Other names
VinexinSCAM1SCAM-1SH3D4SH3-containing adapter molecule 1Sorbin and SH3 domain containing 3vinexin beta (SH3-containing adaptor molecule-1)
02

Biological functions

Structural constituent of cytoskeletonCell spreadingRegulation of actin stress fiber formationMechanotransductionRegulation of focal adhesion dynamicsNegative regulation of autophagy
03

Disease associations

Cardiovascular diseaseNeurodegenerative disease (implicated in brain aging)Cancer (based on cell migration/invasion roles)Delayed wound healing

Beyond the preview

Go deeper on Sorbin and SH3 domain-containing protein 3 (SORBS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sorbin and SH3 domain-containing protein 3 (SORBS3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call